FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996945765> ?p ?o ?g. }

• W1996945765 endingPage "518" @default.
• W1996945765 startingPage "511" @default.
• W1996945765 abstract "Background.—Eletriptan is a potent 5-HT1B/1D agonist with proven efficacy in the acute treatment of migraine in adults. Objective.—To evaluate the efficacy and tolerability of eletriptan 40 mg versus placebo in adolescent patients (aged 12-17). Methods.—A multicenter, double-blind, parallel-group, placebo-controlled trial was conducted comparing 40 mg of oral eletriptan with placebo for the treatment of migraine in adolescent patients. The primary efficacy endpoint was 2-hour headache response, and a number of secondary endpoints were also evaluated. An exploratory analysis evaluated which clinical and demographic characteristics might be correlated with high placebo response. Results.—Of 274 patients who treated a migraine attack, 267 were evaluated for efficacy (n = 138 eletriptan; n = 129 placebo) at 2 hours post-dose. There was no significant difference in 2-hour headache response for eletriptan 40 mg versus placebo (57% vs 57%), and no significant improvements were observed for any of the outcomes at 1 or 2 hours post-dose. By contrast, there was a significant advantage for eletriptan 40 mg in reducing headache recurrence within 24 hours post-dose (11% vs 25%, P= .028), and post hoc analyses showed statistically significant differences for sustained headache response rates (52% vs 39%; P= .04) and sustained pain-free response rates (22% vs 10%; P= .013). The strongest clinical predictor of placebo response was triptan-naïve status (ie, no previous use of any triptan). Eletriptan 40 mg was well tolerated in this population, and the profile of adverse events was similar to that observed in Phase III trials in adult patients. Conclusions.—The high placebo response rates reported here for 1- and 2-hour outcomes are in accordance with other studies of triptans in adolescent patients. The evaluation of treatment effect in adolescent migraine might benefit from use of more stringent outcome measures, such as headache recurrence, sustained headache response, and sustained pain-free response at 24 hours post-dose." @default.
• W1996945765 created "2016-06-24" @default.
• W1996945765 creator A5000448269 @default.
• W1996945765 creator A5020607799 @default.
• W1996945765 creator A5042073172 @default.
• W1996945765 creator A5045036945 @default.
• W1996945765 creator A5073962544 @default.
• W1996945765 creator A5085960628 @default.
• W1996945765 date "2007-04-13" @default.
• W1996945765 modified "2023-10-18" @default.
• W1996945765 title "Eletriptan for the Acute Treatment of Migraine in Adolescents: Results of a Double-Blind, Placebo-Controlled Trial" @default.
• W1996945765 cites W1966827407 @default.
• W1996945765 cites W1986662816 @default.
• W1996945765 cites W1999205715 @default.
• W1996945765 cites W2014845870 @default.
• W1996945765 cites W2015016837 @default.
• W1996945765 cites W2016011428 @default.
• W1996945765 cites W2027261838 @default.
• W1996945765 cites W2039874384 @default.
• W1996945765 cites W2060756080 @default.
• W1996945765 cites W2066537633 @default.
• W1996945765 cites W2067351273 @default.
• W1996945765 cites W2074256173 @default.
• W1996945765 cites W2083727172 @default.
• W1996945765 cites W2086385833 @default.
• W1996945765 cites W2091858211 @default.
• W1996945765 cites W2111937143 @default.
• W1996945765 cites W2112046967 @default.
• W1996945765 cites W2116593011 @default.
• W1996945765 cites W2118874378 @default.
• W1996945765 cites W2137376576 @default.
• W1996945765 cites W2143365051 @default.
• W1996945765 cites W2150542354 @default.
• W1996945765 cites W2151656499 @default.
• W1996945765 cites W2152007006 @default.
• W1996945765 cites W4249480096 @default.
• W1996945765 doi "https://doi.org/10.1111/j.1526-4610.2007.00755.x" @default.
• W1996945765 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17445100" @default.
• W1996945765 hasPublicationYear "2007" @default.
• W1996945765 type Work @default.
• W1996945765 sameAs 1996945765 @default.
• W1996945765 citedByCount "49" @default.
• W1996945765 countsByYear W19969457652012 @default.
• W1996945765 countsByYear W19969457652013 @default.
• W1996945765 countsByYear W19969457652014 @default.
• W1996945765 countsByYear W19969457652015 @default.
• W1996945765 countsByYear W19969457652016 @default.
• W1996945765 countsByYear W19969457652017 @default.
• W1996945765 countsByYear W19969457652018 @default.
• W1996945765 countsByYear W19969457652019 @default.
• W1996945765 countsByYear W19969457652020 @default.
• W1996945765 countsByYear W19969457652022 @default.
• W1996945765 countsByYear W19969457652023 @default.
• W1996945765 crossrefType "journal-article" @default.
• W1996945765 hasAuthorship W1996945765A5000448269 @default.
• W1996945765 hasAuthorship W1996945765A5020607799 @default.
• W1996945765 hasAuthorship W1996945765A5042073172 @default.
• W1996945765 hasAuthorship W1996945765A5045036945 @default.
• W1996945765 hasAuthorship W1996945765A5073962544 @default.
• W1996945765 hasAuthorship W1996945765A5085960628 @default.
• W1996945765 hasConcept C126322002 @default.
• W1996945765 hasConcept C142724271 @default.
• W1996945765 hasConcept C170493617 @default.
• W1996945765 hasConcept C197934379 @default.
• W1996945765 hasConcept C203092338 @default.
• W1996945765 hasConcept C204787440 @default.
• W1996945765 hasConcept C27081682 @default.
• W1996945765 hasConcept C2778375690 @default.
• W1996945765 hasConcept C2778541695 @default.
• W1996945765 hasConcept C2778871607 @default.
• W1996945765 hasConcept C2778938600 @default.
• W1996945765 hasConcept C2908647359 @default.
• W1996945765 hasConcept C42219234 @default.
• W1996945765 hasConcept C46821324 @default.
• W1996945765 hasConcept C535046627 @default.
• W1996945765 hasConcept C67761136 @default.
• W1996945765 hasConcept C71924100 @default.
• W1996945765 hasConcept C99454951 @default.
• W1996945765 hasConceptScore W1996945765C126322002 @default.
• W1996945765 hasConceptScore W1996945765C142724271 @default.
• W1996945765 hasConceptScore W1996945765C170493617 @default.
• W1996945765 hasConceptScore W1996945765C197934379 @default.
• W1996945765 hasConceptScore W1996945765C203092338 @default.
• W1996945765 hasConceptScore W1996945765C204787440 @default.
• W1996945765 hasConceptScore W1996945765C27081682 @default.
• W1996945765 hasConceptScore W1996945765C2778375690 @default.
• W1996945765 hasConceptScore W1996945765C2778541695 @default.
• W1996945765 hasConceptScore W1996945765C2778871607 @default.
• W1996945765 hasConceptScore W1996945765C2778938600 @default.
• W1996945765 hasConceptScore W1996945765C2908647359 @default.
• W1996945765 hasConceptScore W1996945765C42219234 @default.
• W1996945765 hasConceptScore W1996945765C46821324 @default.
• W1996945765 hasConceptScore W1996945765C535046627 @default.
• W1996945765 hasConceptScore W1996945765C67761136 @default.
• W1996945765 hasConceptScore W1996945765C71924100 @default.
• W1996945765 hasConceptScore W1996945765C99454951 @default.
• W1996945765 hasIssue "4" @default.
• W1996945765 hasLocation W19969457651 @default.

• next